Alzheimer’s Disease :: NICE Guidance on Alzheimer’s disease confirms reliance on the MMSE

Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) the global specialty biopharmaceutical company, is disappointed that the overall NICE Guidance excludes newly diagnosed patients with mild AD, despite the revisions published which allow some discretion for clinicians in their reliance on the MMSE when dealing with exceptional patients.

Mental Health :: High-tech diagnosis yields vital clues into mental illness

Is there a definitive test for mental illness? Not yet, but using advanced neuropsychiatric diagnostic tools including magnetic resonance imaging (MRI) and positron emission tomography (PET), mental health professionals at The Menninger Clinic in Houston are pinpointing the causes of behavioral and psychiatric problems in patients.